A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Talking about Malaria

The FDA has since approved numerous antimalaria drugs. Many are not marketed here or are used here only for indications other than malaria.

Chloroquine remains the treatment of choice for patients with malaria caused by species still susceptible to the drug. Resistance to chloroquine is becoming more common, however, and alternative drugs are necessary.

In the United States, Barat says, oral quinine given together with either tetracycline or sulfadoxine-pyrimethamine (Fansidar) is the best regimen for treatment of mild to moderate falciparum malaria acquired in areas where resistance to chloroquine has been identified. For patients with